Any feedback?
Literature summary for 4.4.1.5 extracted from
- Anti-glycative effects of oleanolic acid and ursolic acid in kidney of diabetic mice (2010), Eur. J. Pharmacol., 628, 255-260.
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Mus musculus | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| kidney | - |
Mus musculus | - |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| methylglyoxal + glutathione | - |
Mus musculus | (R)-S-lactoylglutathione | - |
? |  |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| GLI | ambiguous | Mus musculus |
| glyoxalase I | - |
Mus musculus |
Cofactor
| Cofactor | Comment | Organism | Structure |
|---|---|---|---|
| glutathione | - |
Mus musculus | |
Expression
| Organism | Comment | Expression |
|---|---|---|
| Mus musculus | GLI expression is not affected by ursolic acid | additional information |
| Mus musculus | oleanolic acid treatments at 0.1 or 0.2% (v/v) dose-dependently enhances renal glyoxalase I activity and up-regulates renal glyoxalase I mRNA expression | up |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
